Seattle Genetics Offers Data Supporting Antibody-Drug Conjugate, Novel Immuno-Oncology Programs at AACR Meeting
April 18, 2016 at 08:01 AM EDT
Seattle Genetics, Inc. (NASDAQ: SGEN) today highlighted multiple data presentations that support several of the company's antibody-drug ...